Big Data, Real World, Multi-State Study Finds RSV Vaccine Highly Effective in Protecting Older Adults Against Severe Disease, Hospitalization and Death Oct. 17, 2024 — This multi-state study is ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

Researchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.

Infinitopes, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, today ...

Researchers found that influenza vaccination coverage was 80.7% and 45.4% among health care personnel at acute care hospitals and nursing homes.

The Centers for Disease Control and Prevention now recommends that people ages 65 and up and those with weakened immune ...

There’s a reason conservative-leaning figures like Tucker Carlson, Candace Owens, and Charlie Kirk have taken over the ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

COPENHAGEN, Denmark, October 31, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, provides business up ...

Do you want to live in a country where the vice president refers to schools as “soft targets”? That’s a vote for JD Vance. That’s a vote for Donald Trump — a vote for the line on the school shootings ...

Preliminary Q3 2024 PEMGARDA (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with approximately $107 million in cash and cash equivalentsExpects to finish 2024 with $65 million ...

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...